BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

625 related articles for article (PubMed ID: 22841239)

  • 21. [Evidence on the role of HLA and MICA antibodies in renal graft loss].
    Morales-Buenrostro LE; Rodríguez-Romo R; de Leo-Cervantes C; López M; Pérez-Garrido J; Uribe-Uribe N; Alberú-Gómez J
    Gac Med Mex; 2008; 144(4):315-22. PubMed ID: 18942266
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Presensitized kidney graft recipients with HLA class I and II antibodies are at increased risk for graft failure: a Collaborative Transplant Study report.
    Süsal C; Döhler B; Opelz G
    Hum Immunol; 2009 Aug; 70(8):569-73. PubMed ID: 19375472
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Analysis of transplant outcomes after five or six human leukocyte antigen-mismatched living donor kidney transplantation.
    Lee HS; Kim MS; Kim YS; Joo DJ; Ju MK; Kim SJ; Kim SI; Huh KH; Park K
    Transplant Proc; 2012 Jan; 44(1):273-5. PubMed ID: 22310631
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Donor-directed HLA antibodies before and after transplantectomy detected by the luminex single antigen assay.
    Billen EV; Christiaans MH; Lee J; van den Berg-Loonen EM
    Transplantation; 2009 Feb; 87(4):563-9. PubMed ID: 19307795
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Posttransplantation production of donor HLA-specific antibodies as a predictor of renal transplant outcome.
    Worthington JE; Martin S; Al-Husseini DM; Dyer PA; Johnson RW
    Transplantation; 2003 Apr; 75(7):1034-40. PubMed ID: 12698094
    [TBL] [Abstract][Full Text] [Related]  

  • 26. 14th International HLA and Immunogenetics Workshop: report on the Prospective Chronic Rejection Project.
    Ozawa M; Terasaki PI; Lee JH; Castro R; Alberu J; Alonso C; Alvarez I; Toledo R; Alvez H; Monterio M; Teixeira J; Campbell P; Ciszek M; Charron D; Gautreau C; Christiansen F; Conca R; Gomez B; Monteon F; Grosse-Wilde H; Heinemann F; Humar I; Kamoun M; Kimball P; Kobayashi T; Kupatawintu P; Leech S; LeFor W; Mehra N; Panigrahi A; Naumova E; Norman D; Piazza A; Poli F; Colombo B; Roy R; Schonemann C; Sireci G; Tanabe K; Ishida H; Van den Berg-Loonen E; Zeevi A
    Tissue Antigens; 2007 Apr; 69 Suppl 1():174-9. PubMed ID: 17445195
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of de novo human leukocyte antigen and major histocompatibility complex class I chain-related gene-A antibodies and proteinuria with graft survival 5 years after renal transplantation.
    Zhang LW; Peng ZG; Xian WH; Cui XQ; Sun HB; Li EG; Geng LN; Zhao P; Tian J
    Transplant Proc; 2013 Nov; 45(9):3249-53. PubMed ID: 24182794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Long-term follow up for anti-HLA donor specific antibodies postrenal transplantation: high immunogenicity of HLA class II graft molecules.
    Ntokou IS; Iniotaki AG; Kontou EN; Darema MN; Apostolaki MD; Kostakis AG; Boletis JN
    Transpl Int; 2011 Nov; 24(11):1084-93. PubMed ID: 21848902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of anti-human leukocyte antigen, anti-major histocompatibility complex class 1 chain-related antigen a, and anti-glutathione transferase-T1 antibodies on the long-term survival of renal allograft.
    Akgul SU; Oğuz FS; Çalışkan Y; Kekik C; Çağatay P; Türkmen A; Nane I; Aydın F; Temurhan S
    Transplant Proc; 2013 Apr; 45(3):890-4. PubMed ID: 23622580
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum major-histocompatibility-complex class I-related chain A antibody detection for the evaluation of graft dysfunction in renal allograft recipients.
    Zhang M; Lu FM; Qu LX; He J; Yuan XN; Gu Y
    Chin Med J (Engl); 2011 Jul; 124(14):2127-31. PubMed ID: 21933614
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Donor non-specific MICA antibodies in renal transplant recipients.
    Sapák M; Chreňová S; Tirpáková J; Žilinská Z; Ďurmanová V; Shawkatová I; Jakuš V; Kuba D; Buc M
    Immunobiology; 2014 Feb; 219(2):109-12. PubMed ID: 24054943
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Flow cytometric evaluation of pregnancy-induced anti-donor immunization.
    Ayna TK; Ciftci HS; Tozkir H; Sagiroglu T; Isitmangil G; Gurtekin B; Gurtekin M
    Transplant Proc; 2012; 44(6):1656-9. PubMed ID: 22841238
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The clinical significance of human leukocyte antigen antibody development in kidney transplantation.
    Lee PC; Chen YL; Chou TC; Wang WM; Wang JD; Hung CJ; Chang SS; Lin YJ; Chan RH
    Transplant Proc; 2012 Jan; 44(1):264-6. PubMed ID: 22310628
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Anti-human leukocyte antigen and donor-specific antibodies detected by luminex posttransplant serve as biomarkers for chronic rejection of renal allografts.
    Lachmann N; Terasaki PI; Budde K; Liefeldt L; Kahl A; Reinke P; Pratschke J; Rudolph B; Schmidt D; Salama A; Schönemann C
    Transplantation; 2009 May; 87(10):1505-13. PubMed ID: 19461487
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical relevance of Luminex donor-specific crossmatches: data from 165 renal transplants.
    Billen EV; Christiaans MH; van den Berg-Loonen EM
    Tissue Antigens; 2009 Sep; 74(3):205-12. PubMed ID: 19497037
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Detection of HLA and MICA antibodies before kidney graft failure.
    Mizutani K; Shibata L; Ozawa M; Esquenazi V; Rosen A; Miller J; Terasaki PI
    Clin Transpl; 2006; ():255-64. PubMed ID: 18365383
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Influence of cytokine gene polymorphisms on graft rejection in Turkish patients with renal transplants from living related donors.
    Seyhun Y; Mytilineos J; Turkmen A; Oguz F; Kekik C; Ozdilli K; Nane I; Aydin F; Carin M
    Transplant Proc; 2012 Jun; 44(5):1241-9. PubMed ID: 22663993
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prevalence of HLA antibodies and its impact on graft function in a group of kidney transplant recipients: a cross-sectional study.
    Morales-Buenrostro LE; Buzo-Romero JM; de Leo C; López M; Ortiz-Arroyo VM; Pérez-Garrido J; Herrera-Garcia C; Granados J; Alberú J
    Transplant Proc; 2006 Apr; 38(3):899-902. PubMed ID: 16647503
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of donor-recipient relationship on long-term outcomes of living related donor renal transplantation.
    Choi JY; Kwon OJ; Kang CM
    Transplant Proc; 2012 Jan; 44(1):257-60. PubMed ID: 22310626
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of HLA antibodies on graft survival in long-term renal recipients with functional grafts.
    Zeng Y; Liu Z; Liu Y; Fan Y; Guo Y; Qiu J
    Urol Int; 2014; 92(3):328-33. PubMed ID: 24480999
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 32.